Theseus Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 11, 2022 at 12:00 pm
Theseus Pharmaceuticals, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 11.65 million compared to USD 6.81 million a year ago. Basic loss per share from continuing operations was USD 0.3 compared to USD 6.82 a year ago.
For the six months, net loss was USD 22.15 million compared to USD 11.28 million a year ago. Basic loss per share from continuing operations was USD 0.58 compared to USD 11.81 a year ago.